fig1
![Therapeutics to harness the immune microenvironment in multiple myeloma](https://image.oaes.cc/8b396c52-ed4c-4a32-9419-fe4501b455ff/4848.fig.1.jpg)
Figure 1. Direct and indirect effects of FDA-approved and developmental agents on MM cells and their interaction with other cell types within the tumor microenvironment. CAR: Chimeric antigen receptor.
Figure 1. Direct and indirect effects of FDA-approved and developmental agents on MM cells and their interaction with other cell types within the tumor microenvironment. CAR: Chimeric antigen receptor.
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/